Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes()

Human clinical trials in type 1 diabetes (T1D) patients using mesenchymal stem cells (MSC) are presently underway without prior validation in a mouse model for the disease. In response to this void, we characterized bone marrow-derived murine MSC for their ability to modulate immune responses in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fiorina, Paolo, Jurewicz, Mollie, Augello, Andrea, Vergani, Andrea, Dada, Shirine, Rosa, Stefano La, Selig, Martin, Godwin, Jonathan, Law, Kenneth, Placidi, Claudia, Smith, R. Neal, Capella, Carlo, Rodig, Scott, Adra, Chaker N., Atkinson, Mark, Sayegh, Mohamed H., Abdi, Reza
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895445/
https://ncbi.nlm.nih.gov/pubmed/19561093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.0900803
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars